1.
Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research
Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive
Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Europe
Veterinary Pharmaceuticals Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Animal Type (Companion
Animals, Livestock Animals)
5.2.2.
By Product (Parasiticides, Anti-infectives, Anti-inflammatory,
Analgesics, Others)
5.2.3.
By Mode of Administration (Oral, Parenteral, Topical,
Others)
5.2.4.
By Distribution Channel (Veterinary Hospitals &
Clinics, Pharmacies & Retail Store, Digital or E-commerce)
5.2.5. By
Region
5.2.6.
By Company (2022)
5.3.
Product Market Map
5.3.1.
By Animal Type
5.3.2.
By Product
5.3.3.
By Mode of Administration
5.3.4.
By Distribution Channel
5.3.5.
By Region
6. North America Europe
Veterinary Pharmaceuticals Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Animal Type (Companion Animals, Livestock Animals)
6.2.2.
By Product (Parasiticides, Anti-infectives,
Anti-inflammatory, Analgesics, Others)
6.2.3.
By Mode of Administration (Oral, Parenteral, Topical,
Others)
6.2.4.
By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies
& Retail Store, Digital or E-commerce)
6.2.5.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Europe Veterinary Pharmaceuticals Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Animal Type
6.3.1.2.2.
By Product
6.3.1.2.3.
By Mode of Administration
6.3.1.2.4.
By Distribution Channel
6.3.2.
Canada Europe Veterinary Pharmaceuticals Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Animal Type
6.3.2.2.2.
By Product
6.3.2.2.3.
By Mode of Administration
6.3.2.2.4.
By Distribution Channel
6.3.3.
Mexico Europe Veterinary Pharmaceuticals
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Animal Type
6.3.3.2.2.
By Product
6.3.3.2.3.
By Mode of Administration
6.3.3.2.4.
By Distribution Channel
7. Europe Europe
Veterinary Pharmaceuticals Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Animal Type (Companion Animals, Livestock Animals)
7.2.2.
By Product (Parasiticides, Anti-infectives,
Anti-inflammatory, Analgesics, Others)
7.2.3.
By Mode of Administration (Oral, Parenteral, Topical,
Others)
7.2.4.
By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies
& Retail Store, Digital or E-commerce)
7.2.5.
By Country
7.3.
Europe: Country Analysis
7.3.1.
Germany Europe Veterinary Pharmaceuticals Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Animal Type
7.3.1.2.2.
By Product
7.3.1.2.3.
By Mode of Administration
7.3.1.2.4.
By Distribution Channel
7.3.2.
United Kingdom Europe Veterinary Pharmaceuticals Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Animal Type
7.3.2.2.2.
By Product
7.3.2.2.3.
By Mode of Administration
7.3.2.2.4.
By Distribution Channel
7.3.3.
France Europe Veterinary Pharmaceuticals Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Animal Type
7.3.3.2.2.
By Product
7.3.3.2.3.
By Mode of Administration
7.3.3.2.4.
By Distribution Channel
7.3.4.
Italy Europe Veterinary Pharmaceuticals Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Animal Type
7.3.4.2.2.
By Product
7.3.4.2.3.
By Mode of Administration
7.3.4.2.4.
By Distribution Channel
7.3.5.
Spain Europe Veterinary Pharmaceuticals Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Animal Type
7.3.5.2.2.
By Product
7.3.5.2.3.
By Mode of Administration
7.3.5.2.4.
By Distribution Channel
8. Asia-Pacific Europe
Veterinary Pharmaceuticals Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Animal Type (Companion Animals, Livestock Animals)
8.2.2.
By Product (Parasiticides, Anti-infectives,
Anti-inflammatory, Analgesics, Others)
8.2.3.
By Mode of Administration (Oral, Parenteral, Topical,
Others)
8.2.4.
By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies
& Retail Store, Digital or E-commerce)
8.2.5.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
China Europe Veterinary Pharmaceuticals Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Animal Type
8.3.1.2.2.
By Product
8.3.1.2.3.
By Mode of Administration
8.3.1.2.4.
By Distribution Channel
8.3.2.
Japan Europe Veterinary Pharmaceuticals Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Animal Type
8.3.2.2.2.
By Product
8.3.2.2.3.
By Mode of Administration
8.3.2.2.4.
By Distribution Channel
8.3.3.
India Europe Veterinary Pharmaceuticals Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Animal Type
8.3.3.2.2.
By Product
8.3.3.2.3.
By Mode of Administration
8.3.3.2.4.
By Distribution Channel
8.3.4.
Australia Europe Veterinary Pharmaceuticals Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Animal Type
8.3.4.2.2.
By Product
8.3.4.2.3.
By Mode of Administration
8.3.4.2.4.
By Distribution Channel
8.3.5.
South Korea Europe Veterinary Pharmaceuticals Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Animal Type
8.3.5.2.2.
By Product
8.3.5.2.3.
By Mode of Administration
8.3.5.2.4.
By Distribution Channel
9. South America Europe
Veterinary Pharmaceuticals Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Animal Type (Companion Animals, Livestock Animals)
9.2.2.
By Product (Parasiticides, Anti-infectives,
Anti-inflammatory, Analgesics, Others)
9.2.3.
By Mode of Administration (Oral, Parenteral, Topical,
Others)
9.2.4.
By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies
& Retail Store, Digital or E-commerce)
9.2.5.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Europe Veterinary Pharmaceuticals Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Animal Type
9.3.1.2.2.
By Product
9.3.1.2.3.
By Mode of Administration
9.3.1.2.4.
By Distribution Channel
9.3.2.
Argentina Europe Veterinary Pharmaceuticals Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Animal Type
9.3.2.2.2.
By Product
9.3.2.2.3.
By Mode of Administration
9.3.2.2.4.
By Distribution Channel
9.3.3.
Colombia Europe Veterinary Pharmaceuticals Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Animal Type
9.3.3.2.2.
By Product
9.3.3.2.3.
By Mode of Administration
9.3.3.2.4.
By Distribution Channel
10. Middle East and
Africa Europe Veterinary Pharmaceuticals Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Animal Type (Companion Animals, Livestock Animals)
10.2.2.
By Product (Parasiticides, Anti-infectives,
Anti-inflammatory, Analgesics, Others)
10.2.3.
By Mode of Administration (Oral, Parenteral, Topical,
Others)
10.2.4.
By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies
& Retail Store, Digital or E-commerce)
10.2.5.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Europe Veterinary Pharmaceuticals Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Animal Type
10.3.1.2.2.
By Product
10.3.1.2.3.
By Mode of Administration
10.3.1.2.4.
By Distribution Channel
10.3.2.
Saudi Arabia Europe Veterinary Pharmaceuticals Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Animal Type
10.3.2.2.2.
By Product
10.3.2.2.3.
By Mode of Administration
10.3.2.2.4.
By Distribution Channel
10.3.3.
UAE Europe Veterinary Pharmaceuticals Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Animal Type
10.3.3.2.2.
By Product
10.3.3.2.3.
By Mode of Administration
10.3.3.2.4.
By Distribution Channel
10.3.4.
Kuwait Europe Veterinary Pharmaceuticals Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Animal Type
10.3.4.2.2.
By Product
10.3.4.2.3.
By Mode of Administration
10.3.4.2.4.
By Distribution Channel
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13. Porter’s
Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14.
Competitive Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1.
Merck & Co., Inc.
14.6.2.
Vetoquinol SA
14.6.3.
Zoetis Inc.
14.6.4.
Boehringer Ingelheim International GmbH
14.6.5.
Elanco LLC
14.6.6.
Virbac SA
14.6.7.
Laboratorios Calier SA
14.6.8.
Bimeda Corporate
14.6.9.
Prodiet Farmaceutica SA
15. Strategic
Recommendations
16.
About Us & Disclaimer